trial · primary record
Afimkibart
Moderately to Severely Active Ulcerative Colitis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 350 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Percentage of Participants With Clinical Remission |
| Registry ID | NCT07846683 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.385Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07846683
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.